Publication Date
8-18-2023
Journal
iScience
DOI
10.1016/j.isci.2023.107283
PMID
37520701
PMCID
PMC10372839
PubMedCentral® Posted Date
7-14-2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Cardiovascular medicine, Pathophysiology, Molecular microbiology
Abstract
The cardiac fibroblast interacts with an extracellular matrix (ECM), enabling myofibroblast maturation via a process called mechanosensing. Although in the aging male heart, ECM is stiffer than in the young mouse, myofibroblast development is impaired, as demonstrated in 2-D and 3-D experiments. In old male cardiac fibroblasts, we found a decrease in actin polymerization, α-smooth muscle actin (α-SMA), and Kindlin-2 expressions, the latter an effector of the mechanosensing. When Kindlin-2 levels were manipulated via siRNA interference, young fibroblasts developed an old-like fibroblast phenotype, whereas Kindlin-2 overexpression in old fibroblasts reversed the defective phenotype. Finally, inhibition of overactivated extracellular regulated kinases 1 and 2 (ERK1/2) in the old male fibroblasts rescued actin polymerization and α-SMA expression. Pathological ERK1/2 overactivation was also attenuated by Kindlin-2 overexpression. In contrast, old female cardiac fibroblasts retained an operant mechanosensing pathway. In conclusion, we identified defective components of the Kindlin/ERK/actin/α-SMA mechanosensing axis in aged male fibroblasts.
Graphical Abstract
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Biology Commons, Cardiology Commons, Cardiovascular Diseases Commons, Medical Molecular Biology Commons, Pathological Conditions, Signs and Symptoms Commons, Pathology Commons
Comments
Associated Data